Cellogen Therapeutics funding, investors and company details

Cellogen Therapeutics is an emerging Healthcare startup from New Delhi, working in the space of Develops next‑generation cell and gene therapies for cancers and inherited blood disorders. Founded by Gaurav Kharya, Tanveer Ahmad.

Company: Cellogen Therapeutics Private Limited
Sector: Healthcare
Location: New Delhi
Founders: Gaurav Kharya, Tanveer Ahmad

Company overview

Cellogen Therapeutics is a biotech startup that develops next‑generation cell and gene therapies for cancers and inherited blood disorders. The company focuses on advanced CAR T‑cell platforms—such as bispecific, dual‑antigen CAR‑T constructs—to treat blood cancers like leukaemia and lymphoma, aiming to improve efficacy and reduce relapse compared with existing single‑antigen therapies. It also builds gene‑therapy programs for haemoglobinopathies such as beta‑thalassemia and sickle cell disease, with an explicit mission to make these high‑impact treatments available at a fraction of current global prices, mainly targeting underserved Indian and emerging‑market patient populations.

Funding rounds

Latest round: ₹20.00 Cr. ($ 2.10 Mn), 2026-05-18. Investors: Kotak Alternate Asset Management